A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic.
about
Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary careNoise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplonZaleplon: a review of its use in the treatment of insomnia.Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.Advances in the management of insomniaBritish Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent.Treatment of insomnia in hospitalized patients.Effect of sleep apnea on cognition and mood.Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia.Safety of zaleplon in the treatment of insomnia.Problems with sleep: what should the doctor do?Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound EffectsThe Importance of Residual Effects When Choosing a Hypnotic: The Unique Profile of ZaleplonA comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening.The condition of insomnia: etiopathogenetic considerations and their impact on treatment practices.Therapeutic options for sleep-maintenance and sleep-onset insomnia.Clinical evaluation of zaleplon in the treatment of insomnia.Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver.Pharmacotherapy of insomnia: practice and prospects.Dose-related illusions and hallucinations with zaleplon.Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia.Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group.Efficacy of L-846 in patients with insomnia: evaluation by polysomnography.Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.Rapid disappearance of zaleplon from breast milk after oral administration to lactating women.
P2860
Q24670611-28EEBCCB-BEAB-4FD0-B142-E47FEFCB2F99Q24682992-72B19C4C-AB0B-4445-B5D5-C32DC16723A3Q31440135-2C90A6A9-E898-482A-BEC9-B10989FBEB14Q31521391-17614AE6-B6B6-4B5F-A1CD-127D83B48DE7Q33720437-B2EF9864-F8AA-41CD-8D9C-4EE280BDEAE5Q34135759-A355F153-FDAC-47F1-B44C-8BCF1BFE9229Q34156627-D5E2A357-0835-4C26-BB4C-EC8FFB829610Q34449459-64BDB766-99A1-4709-846A-1F0FB89F658DQ34455375-77B11B9B-ECAC-4C25-9A7D-9C2A61A6AE4DQ34473287-BAF4D4B7-9263-4772-BA2D-A59A9443A9B9Q34615602-FDE4B825-D270-49F6-B664-E7DEC0616055Q35109848-3489D389-F687-4D0C-AF77-236FDE7F4EDBQ35664453-C0F3FAE3-9B47-4306-8FDC-9005A13698CFQ35665983-09865F06-ADB3-449B-A55C-F62E98E4973AQ36053686-8C19B759-B031-4A1B-85D0-B7E9EDFEE665Q36272537-A1D1AD7F-5CE1-4993-BB08-A022973FF70EQ36693857-46233116-A9E2-4843-89E4-74322C8E17BBQ36779803-126A897C-522B-4742-8270-EC474FF2C8CCQ38170468-21C5A128-A900-45C0-98E4-BBC77D5D02C9Q40407166-21C720C6-3C9B-4B49-9333-E3DCFDCE5323Q48457239-9A1BDC9F-C9EA-4BB5-8A65-171CFB728383Q48647100-D6240910-7FA7-4C92-B1F0-9CC6E6DE0C95Q48715305-0F767A97-0CED-4656-A51B-0E5DAFC7871AQ48796946-225A02A6-7149-4E22-A252-EDDC9FBC2E99Q52036594-67B9AB23-D9EC-4A91-BD36-D64653BFE996Q52179007-B1A291B2-D553-44D3-A09D-C083A5A81806Q53929338-B98EA44D-081B-4972-B2BA-F11CDF40B442
P2860
A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
A placebo-controlled evaluatio ...... a non-benzodiazepine hypnotic.
@en
A placebo-controlled evaluatio ...... a non-benzodiazepine hypnotic.
@nl
type
label
A placebo-controlled evaluatio ...... a non-benzodiazepine hypnotic.
@en
A placebo-controlled evaluatio ...... a non-benzodiazepine hypnotic.
@nl
prefLabel
A placebo-controlled evaluatio ...... a non-benzodiazepine hypnotic.
@en
A placebo-controlled evaluatio ...... a non-benzodiazepine hypnotic.
@nl
P2093
P2860
P1476
A placebo-controlled evaluatio ...... a non-benzodiazepine hypnotic.
@en
P2093
J Gaudreault
P2860
P304
P356
10.1002/J.1552-4604.1994.TB02002.X
P577
1994-04-01T00:00:00Z